The Global Biliary Atresia Treatment Market is estimated to be valued at US$ 910.7 million in 2021 and is expected to exhibit a CAGR of 7% during the forecast period 2022-2028. Biliary atresia or hepatomegaly is an acquired disease of the liver. The disease is characterized by obstruction of the extrahepatic biliary tract, which obstructs the flow of bile from the liver to the […]
